JI6 is a potent, selective and orally active FLT3 inhibitor, with IC 50 s of ~40, 8, and 4 nM for FLT3-WT , FLT3-D835Y , and FLT3-D835H , respectively. JI6 also inhibits JAK3 and c-Kit , with IC 50 s of ~250 and ~500 nM, respectively. JI6 can be used for the research of acute myeloid leukemia.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > FLT3 | Products > Signaling Pathways > JAK | Products > Signaling Pathways > c-Kit
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.